Evidence map›Paper›PMID 33800412›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells.

Atsushi Kawase, Miho Hirosoko, Yuka Sugihara, Yunosuke Koyama, Ayaka Fukae, Hiroaki Shimada, Masahiro Iwaki

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Atsushi KawaseDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Miho HirosokoDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Yuka SugiharaDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Yunosuke KoyamaDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Ayaka FukaeDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Hiroaki ShimadaDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.
Masahiro IwakiDepartment of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 577-8502, Japan.

Funding

Japan Society for the Promotion of Science 18K06806
6 · The paper itself

Abstract

As increased expression and activities of efflux transporters (ETs) often cause drug resistance in cancers, we tried modulating ET activity in cancer cells, using scaffold proteins such as ezrin/radixin/moesin (ERM) proteins, and Na

Indexed as

interactionpeptidescaffold proteintransporter

Identifiers

PMID33800412
PMCPMC8002045

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.